Image - Barts and The London logo and link to home page Image - divider Image - divider
 
  Image - Wolfson Institute of Preventive Medicine title and link to Institute home page
Images - preventive medicine, people
  Image - Centre for Environmental and Preventive Medicine title and link to Centre homepage
 
Centre for Environmental and Preventive Medicine: publications 1994
Alberman E. (1994). Low birthweight and prematurity. In: The Epidemiology of Childhood Disorders. Pless IB (Ed). New York: Oxford University Press; 49-65.
Alberman ED, Botting B, Blatchley N, Twidell A. (1994). A new hierarchical classification of causes of infant death in England and Wales. Arch Dis Child 70: 403-409.
Cuckle H, Densem J, Wald N. (1994). Repeat maternal serum testing in multiple marker Down's syndrome screening programmes. Prenat Diagn 14: 603-607.
de Courcy-Wheeler RHB, Pomeranz MM, Wald NJ, Nicolaides KH. (1994). Small fetal transverse cerebellar diameter: a screening test for spina bifida. Br J Obstet Gynaecol 101: 904-905.
Dickinson CJ. (1994). Hypertension and central nervous system disease. In: Textbook of Hypertension. Swales JD (Ed). Oxford: Blackwell; 980-985.
Dickinson CJ. (1994). Neurogenic hypertension [in Russian]. Kardiologiya 34: 135-141.
Dickinson CJ. (1994). Clinical research in the NHS today. J R Coll Physicians 28: 460-463.
Law MR. (1994). Opportunistic screening. J Med Screen 1: 208.
Law MR, Morris J, Wald NJ. (1994). Screening for abdominal aortic aneurysms. J Med Screen 1: 110-115.
Law MR, Morris JK, Wald NJ, Hale AK. (1994). Serum albumin and mortality in the BUPA study. Int J Epidemiol 23: 38-41.
Law MR, Wald NJ, Wu T, Hackshaw A, Bailey A. (1994). Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. BMJ 308: 363-366.
Law MR, Wald NJ, Thompson SG. (1994). By how much and how quickly does reducing serum cholesterol lower the risk of ischaemic heart disease? BMJ 308: 367-372.
Law MR, Thompson SG, Wald NJ. (1994). Serum cholesterol. Assessing possible hazards. BMJ 308: 373-379.
Law MR, Wald NJ. (1994). An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990. Eur J Clin Nutr 48: 305-325.
Law MR, Wald NJ. (1994). Commentary on the cholesterol papers: Disagreements are not substantial. BMJ 308: 1027-1029.
Law MR, Wald NJ. (1994). Dietary salt and blood pressure. Lancet 343: 546.
Law MR, Wald NJ, Wu T, Hackshaw A. (1994). Safety of cholesterol reduction remains in doubt. BMJ 308: 1105.
Law MR, Wald NJ, Wu T, Hackshaw A, Thompson SG, Bailey A. (1994). Ischaemic heart disease and cholesterol. BMJ 308: 1041.
Mattu RK, Needham EW, Morgan R, Rees A, Hackshaw AK, Stocks J, Elwood PC, Galton DJ. (1994). DNA variants at the LPL gene locus associated with angiographically defined severity of atherosclerosis and serum lipoprotein in a Welsh population. Arterioscler Thromb 14: 1090-1097.
Morris J. (1994). Screening for malignant melanoma. J Med Screen 1: 2.
Morris J. (1994). Screening for neuroblastoma in children. J Med Screen 1: 141-142.
Morris JK, Cook DG, Shaper AG. (1994). Loss of employment and mortality. BMJ 308: 1135-1139.
Morris JK, Mutton DE, Ide R, Alberman E, Bobrow M. (1994). Monitoring trends in prenatal diagnosis of Down's syndrome in England and Wales 1989-92. J Med Screen 1: 233-237.
Parkes CA, Smith D, Wald NJ, Bourne TH. (1994). Feasibility study of a randomised trial of ovarian cancer screening amongst the general population. J Med Screen 1: 209-214.
Parkes C, Wald N. (1994). Screening for ovarian cancer. An atlas of transvaginal colour doppler: The current state of the art. Kurjak A (Ed). Casterton: Parthenon;317-327.
Tang JL, Law M, Wald N. (1994). How effective is nicotine replacement therapy in helping people to stop smoking? BMJ 308: 21-26.
Wald NJ. The epidemiological approach. In: Textbook of Medicine (Second Edition). Souhami RL, Moxham J (Eds). Edinburgh: Churchill Livingstone; 1-17.
Wald NJ. (1994). Folic acid and neural tube defects: the current evidence and implications for prevention. In: Neural Tube Defects (CIBA Foundation Symposium 181). Chichester: Wiley; 192-211.
Wald NJ. (1994). Medical screening: the way forward. J Med Screen 1: 77.
Wald NJ. (1994). What are we screening for? J Med Screen 1: 205.
Wald NJ. (1994). The prevention of neural tube defects. Federation Focus 18: 8-9.
Wald NJ, Bower C. (1994). Folic acid, pernicious anaemia, and prevention of neural tube defects. Lancet 343: 307.
Wald NJ, Densem JW. (1994). Maternal serum free b-human chorionic gonadotrophin levels in twin pregnancies: Implications for screening for Down's syndrome. Prenat Diagn 14: 319-320.
Wald NJ, Densem JW. (1994). Maternal serum free a;-human chorionic gonadotrophin levels in twin pregnancies: Implications for screening for Down's syndrome. Prenat Diagn 14: 717-719.
Wald NJ, Densem JW. (1994). Primary prevention, screening and diagnosis of neural tube defects. In: Obstetric Ultrasound 2. Neilson JP, Chambers SE (Eds). Oxford: Oxford University Press; 50-72.
Wald NJ, Densem JW, Cheng R, Collishaw S. (1994). Maternal serum free a;- and free b-human chorionic gonadotrophin in pregnancies with insulin-dependent diabetes mellitus: Implications for screening for Down's syndrome. Prenat Diagn 14: 835-837.
Wald NJ, Densem JW, Smith D, Klee GG. (1994). Four marker serum screening for Down's syndrome. Prenat Diagn 14: 707-716.
Wald NJ, Densem JW, Stone R, Cheng R. (1994). The use of free b-hCG in antenatal screening for Down's syndrome. Br J Obstet Gynaecol 101: 176-177.
Wald NJ, Kennard A, Smith D. (1994). First trimester biochemical screening for Down's syndrome. Ann Med 26: 23-29.
Wald NJ, Kennard A, Watt HC, Smith D. (1994). Value of maternal serum unconjugated oestriol measurement in prenatal screening for Down's syndrome. Prenat Diagn 14: 699-706.
Wald NJ, Law M. (1994). Serum cholesterol and disease: Interpreting the evidence. Lipid Insight 6: 1-8.
Wald NJ, Law M. (1994). Serum cholesterol and disease: Interpreting the evidence. Lipid Review 8: 1-10.
Wald N, Law M, Meade T, Miller G, Alberman E, Dickinson CJ. (1994). Use of personal medical records for confidential research purposes. BMJ 309: 1422-1424.
Wald NJ, Law M, Watt H, Wu T, Bailey A, Johnson M, Craig WY, Ledue TB, Haddow J. (1994). Apolipoproteins and ischaemic heart disease: Implications for screening. Lancet 343: 75-79.
Wald NJ, Watt HC. (1994). Choice of serum markers in antenatal screening for Down's syndrome. J Med Screen 1: 117-120.
 
Top
 

Useful links:
  WIPM publications hub
    EPM
    CCP
    Psychiatry
    GPRF/EMCU

by Wolfson Institute Website Manager © Queen Mary, University of London 2011
Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and The London, Charterhouse Square, London EC1M 6BQ Tel: 020 7882 3850 Fax: 020 7882 6270